WASHINGTON – The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its us...
The post Trump opioid plan writes in favoritism to single company’s addiction medication appeared first on Raw Story.
CONTINUE READING >>>